These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29452493)

  • 1. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium.
    Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability.
    Gabr MM; Mortada SM; Sallam MA
    Eur J Pharm Sci; 2018 Jan; 111():1-12. PubMed ID: 28931488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
    Rao MRP; Chaudhari J; Trotta F; Caldera F
    AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste.
    Omar SM; Ibrahim F; Ismail A
    Saudi Pharm J; 2020 Mar; 28(3):349-361. PubMed ID: 32194337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Phospholipid Complex and Submicron Emulsion Techniques for Improving Oral Bioavailability and Therapeutic Efficacy of Water-Insoluble Drug.
    Qin L; Niu Y; Wang Y; Chen X
    Mol Pharm; 2018 Mar; 15(3):1238-1247. PubMed ID: 29412674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability.
    Dora CP; Trotta F; Kushwah V; Devasari N; Singh C; Suresh S; Jain S
    Carbohydr Polym; 2016 Feb; 137():339-349. PubMed ID: 26686138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid.
    Mady FM; Ibrahim SR
    Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution enhancement of atorvastatin calcium by co-grinding technique.
    Prabhu P; Patravale V
    Drug Deliv Transl Res; 2016 Aug; 6(4):380-91. PubMed ID: 26712124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems--enhancement of oral bioavailability.
    Hashem FM; Al-Sawahli MM; Nasr M; Ahmed OA
    Drug Des Devel Ther; 2015; 9():3141-52. PubMed ID: 26150693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol.
    Patil SS; Roy K; Choudhary B; Mahadik KR
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1300-7. PubMed ID: 26651381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of Bioavailability of Non-nucleoside Reverse Transciptase Inhibitor Using Nanosponges.
    Rao MRP; Shirsath C
    AAPS PharmSciTech; 2017 Jul; 18(5):1728-1738. PubMed ID: 27757921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of physicochemical properties and in vivo efficiency of atorvastatin calcium/ezetimibe solid dispersions.
    Jahangiri A; Barzegar-Jalali M; Garjani A; Javadzadeh Y; Hamishehkar H; Asadpour-Zeynali K; Adibkia K
    Eur J Pharm Sci; 2016 Jan; 82():21-30. PubMed ID: 26551750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study.
    Aldosari BN; Almurshedi AS; Alfagih IM; AlQuadeib BT; Altamimi MA; Imam SS; Hussain A; Alqahtani F; Elzayat E; Alshehri S
    AAPS PharmSciTech; 2021 May; 22(5):161. PubMed ID: 34031791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and optimisation of atorvastatin calcium loaded self-nanoemulsifying drug delivery system (SNEDDS) for enhancing oral bioavailability: in vitro and in vivo evaluation.
    Kassem AM; Ibrahim HM; Samy AM
    J Microencapsul; 2017 May; 34(3):319-333. PubMed ID: 28481663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-ε-caprolactone nanoparticles.
    Ahmed IS; El-Hosary R; Shalaby S; Abd-Rabo MM; Elkhateeb DG; Nour S
    Int J Pharm; 2016 May; 504(1-2):70-9. PubMed ID: 27021467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats.
    Mahmoud MO; Aboud HM; Hassan AH; Ali AA; Johnston TP
    J Control Release; 2017 May; 254():10-22. PubMed ID: 28344015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study.
    Ansari KA; Vavia PR; Trotta F; Cavalli R
    AAPS PharmSciTech; 2011 Mar; 12(1):279-86. PubMed ID: 21240574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.